This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seo, T. Articles by Choe, J. Search for Related Content PubMed PubMed Citation Articles by Seo, T. Articles by Choe, J.

Kaposi's Sarcoma–Associated Herpesvirus Viral IFN Regulatory Factor 1 Inhibits Transforming Growth Factor-ß Signaling

Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea

Requests for reprints: Joonho Choe, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Korea. Phone: 82-42-869-2630; Fax: 82-42-869-5630; E-mail: jchoe{at}kaist.ac.kr.

Kaposi's sarcoma–associated herpesvirus, also called human herpesvirus 8, has been implicated in the pathogenesis of Kaposi's sarcoma, body cavity–based primary effusion lymphoma, and some forms of multicentric Castleman's disease. The Kaposi's sarcoma–associated herpesvirus open reading frame K9 encodes viral IFN regulatory factor 1 (vIRF1), which functions as a repressor of IFN-mediated signal transduction. vIRF1 expression in NIH 3T3 cells leads to transformation and consequently induces malignant fibrosarcoma in nude mice, suggesting that vIRF1 is a strong oncoprotein. Here, we show that vIRF1 inhibited transforming growth factor-ß (TGF-ß) signaling via its targeting of Smad proteins. vIRF1 suppressed TGF-ß-mediated transcription and growth arrest. vIRF1 directly interacted with both Smad3 and Smad4, resulting in inhibition of their transactivation activity. Studies using vIRF1 deletion mutants showed that the central region of vIRF1 was required for vIRF1 association with Smad3 and Smad4 and that this region was also important for inhibition of TGF-ß signaling. In addition, we found that vIRF1 interfered with Smad3-Smad4 complex formation and inhibited Smad3/Smad4 complexes from binding to DNA. These results indicate that vIRF1 inhibits TGF-ß signaling via interaction with Smads. In addition, the data indicate the TGF-ß pathway is an important target for viral oncoproteins.

This article has been cited by other articles:

				D. L. Di Bartolo, M. Cannon, Y.-F. Liu, R. Renne, A. Chadburn, C. Boshoff, and E. Cesarman KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor Blood, May 1, 2008; 111(9): 4731 - 4740. [Abstract] [Full Text] [PDF]

				J. Park, M.-S. Lee, S.-M. Yoo, K. W. Jeong, D. Lee, J. Choe, and T. Seo Identification of the DNA Sequence Interacting with Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 J. Virol., November 15, 2007; 81(22): 12680 - 12684. [Abstract] [Full Text] [PDF]

				J.-A. Mendoza, Y. Jacob, P. Cassonnet, and M. Favre Human Papillomavirus Type 5 E6 Oncoprotein Represses the Transforming Growth Factor {beta} Signaling Pathway by Binding to SMAD3 J. Virol., December 15, 2006; 80(24): 12420 - 12424. [Abstract] [Full Text] [PDF]

				S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn Kaposi's sarcoma-associated herpesvirus immune modulation: an overview J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804. [Abstract] [Full Text] [PDF]